Duloxetine News and Research

RSS
Duloxetine is approved in the United States for the acute and maintenance treatment of major depressive disorder, the acute treatment of generalized anxiety disorder, and the management of diabetic peripheral neuropathic pain and fibromyalgia in adults aged 18 years and older. Duloxetine is not approved for use in pediatric patients.
Cymbalta approved for diabetic peripheral neuropathy pain

Cymbalta approved for diabetic peripheral neuropathy pain

Cymbalta, treatment for major depression hits the market

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression

Cymbalta, a new treatment for major depression

Approval of Cymbalta for treatment of major depressive disorder

Approval of Cymbalta for treatment of major depressive disorder

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Cymbalta helped patients with depression feel better

Cymbalta helped patients with depression feel better